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ABSTRACT 
Aldehydes are reactive and ubiquitous in indoor as well as outdoors and can give rise to 
significant health problems in humans, e.g. irritation of the eyes and toxic effects on the upper 
respiratory tract. This thesis focuses on the irritating and inflammatory properties of three 
commonly occurring aldehydes; acrolein, crotonaldehyde and hexanal.  
Male and female volunteers were exposed in a controlled environment at six occasions for 2 
hours to clean air only, 15 ppm ethyl acetate (EA) only and 0.05 ppm and 0.1 ppm acrolein 
with and without EA (Paper I). No significant exposure-related adverse effects (pulmonary 
function, nasal swelling, and inflammatory markers, coagulation markers, cell differentials, 
breathing frequency, symptom ratings except eye irritation) were found. The ratings of eye 
irritation were slightly but significantly increased during exposure to 0.1 ppm acrolein alone 
as well as combined with EA. Blinking frequency was only increased at 0.1 ppm acrolein 
alone.  
Employing a novel olfactometer developed in-house, we determined odor (OT) and 
lateralization (LT) thresholds in naïve subjects (Paper II). The median OTs was similar to or 
lower than previously reported: 17 ppb (acrolein), 0.8 ppb (crotonaldehyde) and 97 ppb 
(hexanal). 
We compared pulmonary pro-inflammatory and oxidative stress responses in seven inbred 
strains of mice after 11 weeks of whole body exposure to 1 ppm acrolein with filtered air as 
the control (Paper III). The responses varied widely between strains, and were in general 
agreement with that expected from previously reported survival times in the same mouse 
strains after acute exposure to 10 ppm acrolein. 
The inflammatory and toxic effects of acrolein (0-0.5 ppm), crotonaldehyde (0-5 ppm) and 
hexanal (0-50 ppm) were further studied in a newly developed exposure system allowing for 
airborne exposure of differentiated human pulmonary bronchial epithelial cells (PBEC) co-
cultured with fibroblasts at an air- liquid interface (Paper IV). The release of inflammatory 
markers and the corresponding mRNA expressions increased. These effects were not 
observed with exposure of PBECs under submerged conditions. 
The findings herein provide new insights in the acute effects of environmentally realistic 
exposure-concentrations of acrolein, crotonaldehyde and hexanal. The results may prove 
helpful in future risk assessment and risk management efforts, such as setting health-based 
occupational exposure limits. 
6 
 
 
                                                                                                  
LIST OF SCIENTIFIC PAPERS 
I. Aishwarya M. Dwivedi, Gunnar Johanson, Johnny C. Lorentzen, Lena 
Palmberg, Bengt Sjögren and Lena Ernstgård; Acute effects of acrolein in 
human volunteers during controlled exposure. Inhalation Toxicology, 2015; 
27 (14); 810-821. 
 
II. Lena Ernstgård, Aishwarya M. Dwivedi, Johan N. Lundström and Gunnar 
Johanson; Measures of odor and lateralization threshold of acrolein, 
crotonaldehyde and hexanal using a novel vapor delivery technique. PLoS 
One, 2017 26; 12 (9): e0185479.  
 
III. Swapna Upadhyay, Aishwarya M. Dwivedi, Lena Ernstgård, Lena 
Palmberg, Lung Chi Chen, Karen Galdanes, Terry Gordon and  Gunnar 
Johanson; Variation of inflammatory and oxidative stress  responses among 
inbred mouse strain following sub-chronic inhalation exposure to acrolein. 
Manuscript. 
 
IV. Aishwarya M. Dwivedi, Swapna Upadhyay, Gunnar Johanson, Lena 
Ernstgård and Lena Palmberg; Inflammatory effects of acrolein, 
crotonaldehyde and hexanal vapors on human bronchial epithelial cells 
cultured at air-liquid interface. Toxicology in Vitro, 2017; (46) 219-228.   
7 
 
TABLE OF CONTENTS 
List of abbreviations ............................................................................................................... 9 
1 Introduction ................................................................................................................... 10 
1.1 Aldehydes ............................................................................................................ 10 
1.1.1 Acrolein ................................................................................................... 12 
1.1.2 Crotonaldehyde ....................................................................................... 14 
1.1.3 Hexanal .................................................................................................... 16 
1.2 Test systems ......................................................................................................... 18 
1.2.1 Human exposure by inhalation ............................................................... 18 
1.2.2 Thresholds for odor and lateralization .................................................... 18 
1.2.3 Mice exposure by inhalation ................................................................... 19 
1.2.4 In-vitro test system .................................................................................. 20 
2 Aims ............................................................................................................................... 22 
3 Materials and Methods .................................................................................................. 23 
3.1 Human volunteers ................................................................................................ 23 
3.2 Exposure of humans via inhalation (Paper I) ..................................................... 23 
3.2.1 The exposure chamber ............................................................................ 23 
3.2.2 Rating of symptoms ................................................................................ 24 
3.2.3 The frequencies of blinking and breathing ............................................. 25 
3.2.4 Pulmonary function ................................................................................. 26 
3.2.5 Nasal swelling ......................................................................................... 26 
3.2.6 Markers of inflammation and coagulation in blood and induced 
sputum ..................................................................................................... 27 
3.3 Thresholds for odor and lateralization (Paper II) ............................................... 27 
3.3.1 The olfactometer ..................................................................................... 27 
3.3.2 Confirmation of the odor threshold using amber bottles ....................... 28 
3.4 Exposure of mice to acrolein (Paper III) ............................................................ 28 
3.4.1 Mice exposure ......................................................................................... 28 
3.4.2 Bronchoalveolar lavage........................................................................... 29 
3.4.3 Preparation of lung homogenate ............................................................. 30 
3.5 RNA/cDNA synthesis ......................................................................................... 30 
3.6 Markers analyzed with the real-time polymerase chain reaction ....................... 31 
3.7 Exposure of the airway mucosa model (Paper IV) ............................................. 31 
3.7.1 Primary bronchial epithelial cells ........................................................... 31 
3.7.2 Culturing human lung fibroblasts ........................................................... 31 
3.7.3 The chamber for exposure of cells.......................................................... 33 
3.7.4 Exposure at air-liquid interface ............................................................... 33 
3.7.5 Submerged exposure ............................................................................... 33 
3.7.6 Cell viability ............................................................................................ 33 
3.7.7 Enzyme-linked immunosorbent assay .................................................... 34 
4 Results and discussions ................................................................................................. 35 
4.1 Exposure of humans via inhalation ..................................................................... 35 
4.1.1 The pilot study ......................................................................................... 35 
8 
 
4.1.2 The main study ........................................................................................ 36 
4.2 Thresholds for odor and lateralization ................................................................ 39 
4.2.1 Validation of our olfactometer ................................................................ 39 
4.2.2 Odor thresholds ....................................................................................... 39 
4.2.3 Lateralization thresholds ......................................................................... 41 
4.3 Exposure of mice to acrolein ............................................................................... 42 
4.3.1 Branchoalveolar lavage ........................................................................... 42 
4.3.2 Markers of inflammatory and oxidative stress markers ......................... 42 
4.3.3 Markers of tissue injury/repair ................................................................ 44 
4.4 Exposure of the airway mucosa model ............................................................... 46 
4.4.1 Cell viability ............................................................................................ 46 
4.4.2 Changes in the levels of IL-8 and MMP-9 ............................................. 46 
4.4.3 Changes in m-RNA levels ...................................................................... 47 
5 Concluding remarks ...................................................................................................... 49 
6 Future perspectives ........................................................................................................ 50 
7 Acknowledgments ......................................................................................................... 51 
8 References ..................................................................................................................... 54 
 
  
9 
 
LIST OF ABBREVIATIONS 
VAS  Visual Analogue Scale 
ALI Air-Liquid Interface 
EMG Electromyography 
CGRP 
Sub P 
EPA 
ACGIH  
PM 2.5 
DALY 
COPD 
ROS 
NOAEL 
LOAEL 
BAL 
IARC 
HBEC 
GO  
OT 
TRP 
TRPA1 
PBEC 
MCA 
PEF 
MRC-5 
ELISA 
IL-6  
CRP 
SAA 
IL-8 
CC-16 
 
Calcitonin Gene Regulated Peptide  
Substance P 
Environmental Protection Agency 
American Conference of Government Indistrial Hygienists  
Particulate Matter 2.5 
Disability Adjusted Life Year 
Chronic Obstructive Pulmonary Disease  
Reactive Oxygen Species 
No Observed Adverse Effect Level 
Lowest Observed Advese Effect Level 
Branchoalveolar lavage 
International Agency for Research on Cancer 
Human Bronchial Epithelial Cell 
Gene Ontology 
Odor Threshold 
Transient Receptor Potential 
Transient Receptor Potential Ankyrin 1 
Primary Bronchial Epithelial Cell 
Minimum Cross Sectional Area 
Peak Expiratory Flow 
Medical Research Council cell strain-5 
Enzyme-Linked Immunosorbent Assay 
Interleukin-6 
C-Reactive Protein 
Serum Amyloid A 
Interleukin-8 
Club Cell  
  
 
10 
 
1 INTRODUCTION 
1.1 ALDEHYDES 
Aldehydes are a large class of electrophilic carbonyl compounds containing functional –CHO 
group to which humans are ubiquitously exposed [1]. In spite of the fact that such exposure 
poses a significant risk to health, the mechanisms underlying aldehyde toxicity remain poorly 
understood, at least in part because of the structural diversity of these compounds and their 
wide range of biological targets [2]. In addition to occurring naturally, aldehydes are derived 
from anthropogenic sources and even produced endogenously. 
This family of chemicals can be divided into four major sub-classes on the basis of the 
presence of corresponding structure that incorporates additional functional moieties (Table 1).  
Table 1: Classification, examples and uses of aldehydes 
Classification of aldehyde Examples of aldehydes Industrial uses 
Aliphatic aldehydes Formaldehyde, Acetaldehyde 
and Hexanal 
Monomer for polymer 
(resins), component of 
disinfectant, germicide, 
perfume, dyes  
Aromatic aldehydes Benzaldehyde and Vanillin Chemical synthesis of 
components of dyes, 
perfumes and flavoring 
agents. 
Unsaturated aldehydes Acrolein, Crotonaldehyde Chemical synthesis of, eg. 
methionine, sorbic acid and 
also used as algicide and 
herbicide. 
α-Oxoaldehydes   Glyoxal, Glycolaldehyde, 
Glyoxylic acid 
Leather tanning, cross 
linking of starch and for 
water treatment 
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Aldehydes can be detoxified in two ways: 
1. Oxidation by aldehyde dehydrogenase to produce corresponding carboxylic acids. 
2. Conjugation with sulfhydryl groups, especially in glutathione (GSH), which decreases 
glutathione levels and leads to oxidative stress or results in an suppression of aldehyde 
dehydrogenase.  
In this thesis, the health effects of the aldehydes (acrolein, crotonaldehyde and hexanal) have 
been examined employing different experimental models. Chemical structures are presented 
below (Figure 1) 
 
 
 
 
Figure 1: Chemical structures of aldehydes 
 
 
 
 
 
 
 
 
 
 
 
 
Acrolein Crotonaldehyde Hexanal 
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1.1.1 Acrolein  
1.1.1.1 Occurrences and levels of exposure  
Acrolein (2-propenal), a reactive α, β unsaturated aldehyde is produced upon combustion of 
wood, plastic, gasoline, diesel fuel or  paraffin wax, as well as in connection with smoking 
and cooking [3-6] (Figure 2). This compound is also produced to a lesser extent through 
biological process in higher organisms, and by human and microbial activities [7].  
Acrolein is considered to pose one of the greatest non-cancerous health risks of all hazardous air 
pollutants [8]. Extensive increases in the incidences of chronic lung diseases, including 
childhood asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD), 
during the past 15 years have led to considerable focus on the quality of indoor air [9, 10]. 
Especially, since inhabitance of the United States and Europe spends approximately 90% of 
their time indoors. While there is abundant data on common pollutants such as formaldehyde 
and carbon monoxide, very little is presently known about the indoor sources, levels, and fate 
of acrolein and other aldehydes. Indoor levels of acrolein have been found consistently to be 
higher (0-29 μg/m3) than outdoors [11, 12] 
The levels of acrolein in kitchen air vary in connection with the heating of oils and fats, 
having been reported to be in Norwegian restaurant kitchens approximately 0.004 ppm (0.0- 
0.013 ppm) [13] and  0.03- 0.26 ppm in Finnish restaurants [14]. In addition, levels of 
acrolein were approximately 0.004 ppm in connection with food processing; 0.008 ppm in 
bakeries [14] and more than 44 ppm during fires [15] have been reported. Firefighters have 
been exposed to concentrations as high as 3 ppm [16]. 
Little is presently known about the acute health effects of acrolein on human. A limited early 
investigation from the 1970’s revealed that exposure to approximately 0.17 ppm for, few 
minutes to causes mild eye irritation, which becomes even more pronounced at 0.26 ppm 
[17]. Among 1192 substances in indoor air, particulate matter (PM 2.5), acrolein and 
formaldehyde have been listed as exerting the greatest cumulative impact on health in the 
United States, Whereas, the overall non-cancer impact of acrolein is estimated to result in 47 
DALYs (Disability Adjusted Life Years) per 1000 residents annually [5]. Similarly, in Japan 
among 93 substances in indoor air, formaldehyde and acrolein were considered to be 
associated with the highest risk [18]. However, such calculations are highly uncertain, since 
very few measurements of air levels are available and extrapolating from high to low dose is 
problematic. Elevated levels of metabolites derived from acrolein and crotonaldehyde have 
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been detected in non-smoking Asian women who regularly cook wok and a direct 
relationship between frequency of wok cooking and exposure to airborne aldehydes has been 
proposed [19]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Exposure sources of acrolein 
1.1.1.2 Health effects of acrolein 
Acrolein is a risk factor for many diseases occurring throughout the body, including chronic 
pulmonary disease, airway neurogenic inflammation, neurodegenerative disorders, 
cardiovascular disease, diabetes mellitus, neurohepato and nephrotoxicity (Figure 3). Because 
of its simple structure and volatility, acrolein quickly crosses the plasma membrane of cells 
and causes a variety of adverse intracellular effects, including mitochondrial and death 
receptor pathways for apoptosis and necrosis [20-22]. Furthermore, oxidative stress is 
induced by acrolein [23-26], by binding to DNA and proteins. Such processes can lead to, 
mitochondrial disruption, membrane damage, endoplasmic reticulum stress and immune 
dysfunction (Figure 3, [27]). 
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Figure 3: Mechanisms of underlying acrolein toxicity 
 
As a strong electrophile, acrolein has great affinity for nucleophiles. A few such nucleophile 
groups are the sulfhydryl group of cysteine, imidazole group of histidine and amino group of 
lysine. The most significant interactions between acrolein and cellular molecules involve 
proteins and tri-peptides such as glutathione, which is required for the maintenance of redox 
homeostasis [28]. Acrolein undergoes nucleophilic Michael addition to form adducts or 
Schiff base cross-links [29, 30], with susceptible amino acid residues that play important 
enzyme catalysis, redox signaling, production of reactive oxygen species (ROS) and cellular 
buffering. Thus, adduction by acrolein may significantly alter in protein functions and disrupt 
the intracellular thiol redox equilibrium.  
Furthermore, acrolein binds to DNA to form cyclic adducts and crosslinks [31-36]. In 
particular, this aldehyde reacts rapidly with deoxyguanosine (dG) to produce two exocyclic 
DNA adducts, a- and c-hydroxy-1, N2-propano-20- deoxyguanosine (a-HOPdG and c-
HOPdG). If not repaired quickly, such DNA adducts may lead to mutations. Suggesting may 
contribute to the process of carcinogenesis [34]or other diseases [27]. 
1.1.2 Crotonaldehyde 
1.1.2.1 Occurrence and levels of exposure  
Although chemically similar to the acrolein, crotonaldehyde is less toxic, but still considered 
to be an important environmental and industrial pollutant [37]. Environmentally, 
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crotonaldehyde is produced by combustion of fossil fuel, tobacco and wood, as well as 
heating of cooking oil. This aldehyde is an odorous constituent in aircraft emission, has been 
detected at high levels in cigarette smoke (10-228 μg/cigarette [38, 39] and smoke from wood 
fires (6-116 mg/kg wood [40]). Industrially, crotonaldehyde is primarily used in manufacture 
of chemicals such as butanol and sorbic acid, which constitute one of major sources of human 
occupational exposure. Moreover, crotonaldehyde is present naturally in small amounts in 
many food items, the air in pine and deciduous forests in Europe and gases emitted by 
volcanoes [39]. Since it binds to guanine residues in DNA and also modulates certain 
immunological functions, the Environment Protection Agency (EPA) has classified this 
aldehyde as a possible carcinogen. Crotonaldehyde is highly irritating to the eyes, nose, 
mucous membranes, upper respiratory tract and skins of humans and other animals [41-43].  
1.1.2.2 Health effects of crotonaldehyde  
In rodents crotonaldehyde causes gastric, respiratory and hepatic toxicity. As well as being 
involved in hepatocarcinogenesis [44]. On the basis of the hepatocellular carcinomas and 
hepatic neoplastic nodules it evokes in male rats, crotonaldehyde has been classified as a 
Group 3 carcinogen by the International Agency for Research on Cancer (IARC).  However, 
data on its potential human carcinogenicity are lacking. The potential carcinogenicity 
of crotonaldehyde is supported by its genotoxicity in vitro and it is also a suspected 
metabolite of N-nitrosopyrrolidine, a probable human carcinogen [45].  
Crotonaldehyde is a highly selective respiratory toxic and that may lead to chronic pulmonary 
diseases by altering a variety of cell signaling cascades, including those involved in 
inflammatory responses.  Little has been known about the possible induction of oxidative 
stress by this compound. There is some evidence that with its electrophilic olefin and 
carbonyl groups, crotonaldehyde is highly active towards cellular nucleophiles generation, 
e.g., DNA and protein adducts [46, 47]. Other studies show that α, β-unsaturated aldehydes 
can inhibit cytokine gene expression by alkylating NFkappaB1 [48, 49] but, there is presently 
little information concerning alteration of gene expression by crotonaldehyde. As an 
aldehyde, this compound can be detoxified by hydrogenation or oxidation.  
The few investigations of global transcriptional responses to exposure to crotonaldehyde 
reported to date have been performed on THP-1 cells (Human monocyte leukemia cell line), 
human bronchial epithelial cells (HBECs) and alveolar macrophages. In the case of HBECs, 
the genes whose expression is altered code for protein involved in oxidative stress, caspase-
dependent apoptosis and cytokine signaling [50, 51]. Crotonaldehyde induces apoptosis, 
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immunosuppression and release of IL-8 in alveolar macrophages [52, 53]. Lee and colleagues 
(2011) reported that in human umbilical vein endothelial cells crotonaldehyde induces HO-1 
expression, an adaptive response to oxidative stress and mediated by the PKC-Ϩ-p38MAPK-
nrf2-HO-1 pathway [54]. Recently, crotonaldehyde has also been found to mediate anti-
apoptotic effects in human endothelial cells by upregulating heat shock protein 72 (hsp 72) 
[55]. Nonetheless, the mechanism underlying the adverse effects of this aldehyde on 
respiratory health, remain to be elucidated. 
1.1.3 Hexanal 
1.1.3.1 Occurrences and exposure levels  
Hexanal a colorless liquid that smells like green grass is present naturally in many fruits and 
vegetables. This alkyl aldehyde is also found in human biofluids (milk, blood, Saliva)  [56] 
and is a major indoor air pollutant [57]. In addition, this compound is present in volatile 
organic mixtures used as flavoring additives in cigarettes, fragrances and the food industry, 
moreover, is emitted in large amount from stored wood pellets and fiber boards of medium 
density [58]. It is also used in the synthesis of plasticizers, rubber chemicals, dyes, synthetic 
resins and insecticides. Hexanal is generated through oxidative cleavage of ω-6 unsaturated 
fatty acids, such as linoleic or arachidonic acid [56].  
Hexanal can initiate mutagenesis and carcinogenesis, regulate growth and signaling; and 
mildly irritating to the eyes and nose [58]. As a breakdown product of the oxidation of 
linoleic acid this aldehyde arises in connection with lipid peroxidation and alteration in flavor 
of food. The "cardboard-like" flavor of hexanal is frequently associated with spoiling 
dehydrated milk products and this compound has been proposed as a potential marker of milk 
quality [59]. 
1.1.3.2 Health effects of hexanal 
Hexanal may exerts adverse health effects on humans. When 12 healthy human volunteers 
were exposed to 0, 2, and 10 ppm of  hexanal for 2 hours in a controlled chamber, ratings of 
blinking frequency were significantly increased at the highest dose [58]. No changes on 
pulmonary function and nasal swelling were observed except for a non-significant tendency 
towards nasal obstruction at 10 ppm. Nor were there any clear effects on the plasma 
inflammatory markers (C-reactive protein (CRP) and interleukin-6 (IL-6)). These 
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investigators concluded that, two hours of exposure to 10 ppm of hexanal results in mild 
irritation, with no such impact at 2 ppm [58]. 
Moreover, 0.1% hexanal depresses the motility of human spermatozoa but without ever 
causing complete immobility [60]. In addition, low molecular weight aldehydes, 
including hexanal, may interfere with cholesterol transport and gap junctional intercellular 
communication in human smooth muscle cells [61]. 
Exposure to a concentrated vapor of hexanal (2000 ppm) for 1 hour or 4 hours results in 
mortality in rats and is cytotoxic towards the hepatocytes of these animals [62]. Rats 
consuming diets containing hexanal for three weeks exhibited attenuated 
serum cholesterol and triglycerides levels. In addition, hexanal stimulates dopamine release, 
but does not inhibit dopamine uptake in the brain striatum of rats and alters length of time 
during which virgin females display maternal crouching. In one study on mice hexanal 
influenced maternal behavior and led to neonatal death [63]. Hexanal is also mutagenic 
towards mammalian cells, producing single-strand DNA breaks or lesions which are 
converted to such breaks by alkali [64]. 
The mechanisms underlying of hexanal toxicity is poorly defined. When Fisher 344 rats were 
exposed by inhalation exposure to 0, 600, 1000, and 1500 ppm of hexanal vapors for 4 
hours/day, 5 days/week for 4 weeks and alterations in the expression of 56 genes in were 
revealed by microarray based genome wide expression analysis [65]. Of these 56 genes, 11 
demonstrated dose-dependent changes and the expression of 10 was downregulated and the 
other upregulated at least1.5-fold (p< 0.05). Cho and coworkers found by comparative 
analysis of toxicogenomic databases (CTD) analysis that five of these 11 genes (CCL12, 
DDIT4, KLF2, CEBPD, and ADH6) are linked to diverse categories of disease such as 
cancer, respiratory tract disease, and immunological diseases all known to be caused by 
volatile organic compounds (VOCs). Gene ontology (GO) analysis and mi-RNA and m-RNA 
interaction analysis of A549 (human alveolar cells) led to the conclusion that the key 
biological process affected by exposure to hexanal are involved in neurological processes,  
development of the immune system, cell activation and cell-cell signaling [66]. Accordingly, 
dose dependent alterations in gene expression can help to predict hexanal induced pulmonary 
toxicity and carry out relative risk assessments.  
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1.2 TEST SYSTEMS 
1.2.1 Human exposure by inhalation  
The general population is exposed to aldehydes by inhalation, ingestion, and dermal contact 
with food and other items. Aldehydes are common indoor and outdoor pollutants, so that 
exposure via inhalation route is common. On the basis of our previous experience of 
performing human exposure studies on different solvents [58, 67-70], we have exposed 
humans to vapors of acrolein by inhalation in an exposure chamber (Figure 4, page 24). After 
such exposure to vapors of solvents or clean air (as a control exposure), acute effects on 
human healthy volunteers could be assessed. One major advantage of this type of exposure is 
that individuals serve as their own controls, so that even small effects can be detected. These 
inhalation exposure studies may provide information concerning threshold levels (NOAEL, 
no observed adverse effect level and LOAEL, lowest observed adverse effect level) for acute 
irritation and inflammation of solvents and thus improve the scientific basis for setting 
exposure limits in our own country as well as within the entire European Union.  
1.2.2 Thresholds for odor and lateralization  
Sensory irritation is a general term, including both the irritation of eyes and the upper 
airways. The sensory irritants acrolein and crotonaldehyde excite peripheral nerves to induce 
pain and respiratory irritation [71] and such neuronal activation is immediate. Stinging pain 
and lachrymation in the eyes results from activation of the trigeminal nerve ending in the 
cornea by these aldehydes. Whereas, stimulation of trigeminal nerve endings in the nose, as 
well as vagal laryngeal sensory nerve endings triggers upper airway irritation, pain, sneezing, 
coughing and nasal discharge [72]. On the other hand, hexanal, is an indoor air irritant but not 
a strong odorous irritant [73], is very unlikely to produce sensory irritation at the levels 
present in indoor air.  
Most aldehydes have very strong odor, which limits risk evaluation based on the quality or 
intensity of odor. Indeed, detection of odor correlates poorly with toxicology and the 
relationship between odor and irritation is unclear with many substances eliciting odor at very 
low concentrations and irritation at very high concentrations. The odor threshold (OT), i.e., 
the lowest concentration of a compound which can be perceived by the human sense of smell, 
has proven to be difficult to determine for individuals with normal olfaction. The OT of a 
chemical depends on its shape, polarity, partial charges and molecular mass.  
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Odor interferes with the measurements of irritation, presumably because of ambiguity 
regarding the point at which an odor itself becomes an irritation and the sensation takes on an 
irritation character via stimulation of the trigeminal nerve. The lateralization threshold (LT) is 
the concentration at which individual can discriminate which nostril is being exposed, which 
requires sensory stimulation of the trigeminal nerve.  
1.2.2.1 Involvement of the TRPA1 in toxicological injury 
Transient receptor potential (TRP) ion channels located in the plasma membrane and 
membrane of intracellular organelles, participate in maintaining the homeostasis of 
intracellular Ca
2+ 
[74, 75]. The 28 known TRP channels are grouped into seven subfamilies: 
TRPC, TRPV, TRPM, TRPP, TRPML, TRPA, and TRPN) and each sub-family includes one 
or more members [76]. 
Transient receptor potential ankyrin 1 (TRPA1), a cation channel is expressed in TRPV1-
positive neurons of all sensory ganglions (trigeminal, vagal and dorsal root), a target for   
environmental irritants such as acrolein, crotonaldehyde, tobacco smoke, mustard gas and 
diesel exhaust fumes. For instance, these receptors are the neuronal target for isothiocynate 
and thiosulfinate compounds, which are present in mustard oil and wasabi. Acrolein activates 
both human and rodent TRPA1 [72] and crotonaldehyde also acts as an environmental 
agonist of this receptor [77]. 
As described earlier, acrolein and crotonaldehyde both are strong electrophiles and as such 
they bind to the cysteine residue of TRPA1, thereby opening of cation channel and allowing 
calcium to enter which leads to neuronal activation and secretion of substance P (SubP) and 
calcitonin gene regulated peptide (CGRP). This sequential process aggravates both local and 
coordinated inflammatory responses, including elevated blood flow, vascular permeability 
and sensation of pain [77]. SubP and CGRP are responsible for these highly localized effects 
of TRPA1. Thus α, β-unsaturated aldehydes stimulate TRPA1 mediated inflammation, which 
may contribute to cardiopulmonary toxicity  [78]. Oxidative stress, a hallmark of most acute 
and chronic inflammation of the airways, also excites sensory nerve fibers in the airways, 
resulting in respiratory depression [72, 77] 
1.2.3 Mice exposure by inhalation 
Animal models are frequently used as an alternative to investigate the mechanisms and 
progression of chronic lung diseases in humans. It is very unlikely that a single animal model 
will provide information regarding morphological and functional features of diseases. 
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However, laboratory animals (guinea pig, rat and mouse) are employed to describe 
underlying mechanism for lung diseases. Mouse is the most widely used species, mainly 
because of the availability of transgenic animals. We employed seven inbred mice strains to 
better understand their susceptibility and pulmonary oxidative stress, pro-inflammation and 
tissue injury caused by sub-chronic exposure to acrolein (Paper IV). The selection criteria are 
based on their availability and frequent use in respiratory research.  
1.2.4 In-vitro test system 
Researches are attempting to adhere to the 3R principals of reduction, refinement and 
replacement of animal experimentation and thus feasible alternatives are being developed. 
Submerged monocultures of transformed and immortalized cell lines have provided 
important tools not only for unraveling mechanisms of toxicity, but also for characterizing 
thousands of pharmaceutical compounds over the past decades. Despite this extensive 
usefulness, more sophisticated models that mimic the physiological situation more closely 
and include two or more cellular lineages of epithelial and immune cells, are desirable [79].  
Fibroblasts play an important role in epithelial cell function, contributing to the spatial 
distribution required for long-term maintenance of mucociliary phenotype [80]. In recent 
years, several approaches to optimal inclusion of fibroblasts in 3D airway models have been 
proposed [81]. Indeed, Pezzulo and colleagues (2011) have shown that fibroblasts are 
required for the differentiation of epithelial cells and by embedding different immune 
components to dual or triple co-cultures pseudo-tissues like structures can be achieved [82]. 
This approach has been employ to characterize mechanism of immune defense and elucidate 
paracrine signaling by cytokines on the epithelium [83].  
The cell types available for modelling the human respiratory system include primary cells 
from humans or animals and submerged immortalized cell lines (BESE-2b, 16-HBE, A549). 
Unfortunately, the extensive recent findings from submerged cultures are not directly 
applicable to humans, because in such submerged systems cells fail to differentiate. To 
recreate the pseudostratified epithelium in vivo, primary bronchial epithelial cells (PBECs) 
have been cultured at air-liquid interface (ALI) [82, 84] an arrangement recapitulates the 
conditions present in the human airway and promotes mucociliary differentiation. 
To mimic the in vivo situation, PBECs are seeded on either collagen based or permeable 
inserts. Routinely, these cells are allowed to grow submerged until they become confluent, 
and then the media is removed from underneath to grow the cells at air-liquid interface (ALI) 
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until they fully differentiated [85]. Such models of airway mucosa contribute towards a 
unique opportunity to reduce and refine animal experimentation, while providing relevant 
insights on particle, gaseous inhalation toxicity and the integrity of the airway epithelium.  
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2 AIMS 
The overall aim of the current project was to investigate the acute adverse effects, with 
primary focus on irritation and inflammation of acrolein and other aldehydes present in 
indoor environments. 
Our specific aims were: 
 To estimate the threshold levels for acute irritation of acrolein in human volunteers 
exposed via inhalation. (Paper I) 
 
 To obtain insight into the thresholds for odor and irritation by acrolein, cotonaldehyde 
and hexanal in human volunteers employing a novel olfactometer. (Paper II) 
 
 To charecterize the sub-chronic pulmonary toxicity in induced in seven inbred strains 
by acrolein. (Paper III) 
 
 To assess the inflammatory responses and cytotoxicity of a sophisticated mucosa 
model including PBECs exposed to vapors of acrolein, cotonaldehyde and hexanal, 
and to compare the levels of m-RNA encoding inflammatory markers at an air-liquid 
and cells from submerged culture. (Paper IV) 
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3 MATERIALS AND METHODS 
This section summarizes several novel methods and experimental models employed here to 
examine the acute health effects of acrolein, crotonaldehyde and hexanal, with more detailed 
descriptions in the accompanying papers and manuscript. Two studies were performed on 
human healthy volunteers, one on inbred mice exposed to acrolein, and the fourth with 
PBECs from humans. 
3.1 HUMAN VOLUNTEERS 
Subjects were recruited by advertisement at Karolinska Institutet, Stockholm University, the 
Royal Institute of Technology, and on a web page designed for recruitment of research 
volunteers. The inclusion criteria were; an age between 20-50 years, good health, non-smoker 
and non-pregnant. Prior to exposure a medical examination of each participant and a 
pregnancy test on all of the women were performed. The volunteers were informed about the 
design of the studies, possible hazards, and their right to immediately and unconditionally 
withdraw from the study. Both of these studies (Papers I & II) were performed in accordance 
with the Helsinki declaration and pre-approved by the Regional Ethical Review Board in 
Stockholm. To ensure that the subjects had a normal sense of smell, they underwent an 
anosmia screening test based on the Sniffing Sticks, before participating in the study on odor 
and irritation thresholds.  
3.2 EXPOSURE OF HUMANS VIA INHALATION (PAPER I) 
3.2.1 The exposure chamber  
Volunteers were exposed in a 20-m
3
 dynamic chamber of glass and inert material with 
monitoring of the temperature, relative humidity and levels of carbon dioxide (Figure 6). 
Vapors were generated by injecting liquid acrolein (0.1 %) and ethyl acetate (EA) (used to 
mask the odor of acrolein in the main study) into the inlet air with a high pressure 
chromatography piston pump and subsequent dispersion through the chamber ceiling. To 
assess the odor and irritation of acrolein and set an exposure limits for main study a pilot 
study was performed. In the pilot study, the volunteers were exposed to increasing 
concentrations of acrolein (0.02, 0.04, 0.07, 0.1, 0.2 and 0.3 ppm) for 10 minutes.   
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Figure 4: The human exposure chamber  
3.2.2 Rating of symptoms  
The symptoms related to the eyes, nose throat, smell and CNS listed below were rated on 
visual analog scales (VAS) as follows: 
 
 
 
 
 
 
 
 
 
not at all  
hardly  
 at all  
somewhat rather  quite very  
 
almost  
unbearable 
1. Discomfort in the eyes: burning or irritattion 
2. Discomfort in the nose: burning, irritattion, or runny nose  
3. Discomfort in the throat or airways 
4. Breathing difficulty 
5. Smell 
6. Headache 
7. Fatigue 
8. Nausea 
9. Dizziness 
10. Feeling of intoxication 
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3.2.3 The frequencies of blinking and breathing  
As a measure of eye irritation, blinking frequency of the left eye was monitored by 
electromyography (EMG) via three skin electrodes, two on the M. orbicularis oculi and a 
reference electrode on the cheek bone (Figure 5). Breathing frequency was measured by 
respiratory inductive plethysmography employing a flexible belt mounted around the 
volunteer’s chest (Figure 5). 
 
 
 
 
 
 
 
 
 
 
 
Figure 5:  (Left) Volunteer equipped with EMG electrodes for recoding of blinking 
frequency, an inductive flexible chest belt for recording of breathing frequency and a data 
logger (black box).  (Right) Recordings of the blinking and breathing frequencies 
 
 
 
 
 
 
 
Blinkning Frequency  
Breathing Frequency   
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3.2.4 Pulmonary function  
Pulmonary function tests were performed with a spirometer and accompanying computer 
software. The parameters measured included vital capacity (VC), forced vital capacity (FVC), 
forced expiratory volume in 1 s (FEV1), peak expiratory flow (PEF) and forced expiratory 
flow at 5%, 50%, and 75% of FVC (FEF25, FEF50, FEF75) (Figure 6). 
 
 
 
 
 
 
 
 
 
Figure 6: Spirometry measurements 
3.2.5 Nasal swelling  
To assess the effect of acrolein on nasal swelling, the minimal cross- sectional area (MCA) 
and volume of the nose were measured by acoustic rhinometry at two distances (0 to 22 mm 
and 23 to 54 mm) from the opening of the nose (Figure 7). This approach evaluates nasal 
obstruction by analysing reflections of a sound pulse introduced into the nostrils.  
 
 
 
 
 
 
 
 
 
Figure 7: Measurement by acoustic rhinometry  
1 3 
4 
5 
1 Sound generator 
2 Sound tube 
3 Nose piece 
4 Computer 
5 Amplifier 
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The blocking index (BI), a measure of the nasal airway resistance, was also calculated as the 
difference between the PEF values for the mouth and nose, divided by the mouth PEF value 
[86]. 
3.2.6 Markers of inflammation and coagulation in blood and induced sputum 
The levels of interleukin-6 (IL-6), C-reactive protein (CRP), serum amyloid A (SAA), 
fibrinogen, factor VIII, von-Willebrand factor (vWF) and club cell (CC16) in blood were 
analyzed. Sputum was induced only with case of control and high-level exposure to acrolein, 
was examined with the respect to the cells present and with measurement of IL-6 and IL-8 
levels.  For a more detailed description of these methods please see Paper I.  
3.3 THRESHOLDS FOR ODOR AND LATERALIZATION (PAPER II) 
3.3.1 The olfactometer  
The thresholds of aldehydes for odor and irritation were determined with a novel, inexpensive 
olfactometer consisting of syringes attached to pumps, each connected to a Tedlar bag 
containing a specific concentration of the test chemical in air (Figure 8). To determine the 
threshold for the detection of odor, a small amount of air (with or without aldehyde) was 
pumped into the nose piece and the volunteers were asked to decide whether he/she was 
inhaling aldehyde vapor or clean air. To determine the lateralization threshold clean air was 
pumped into one nostril and aldehyde vapor into the other, starting at the odor threshold. The 
volunteer then decided in which nostril the aldehyde was present. To determine the 
concentration range to be employed, a pilot study involving a wide range of concentrations 
was performed and the range that included most of the volunteers tested were selected for use 
the main study. Further description of the olfactometer, as well as of how the vapors were 
generated and tested is presented in Paper II. 
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 Figure 8: The olfactometer 
(Components of olfactometer are: 1=Syringe pump, 2=Syringes, 3=Teddlar bags, 
4=Multiport connector, 5=Adapter, 6=Luer, 7=Female Luer, 8=Adapter pipe, 9=Stopcock, 
10=Teflon tubes). Adapted from Paper II, with permission from publisher. 
3.3.2 Confirmation of the odor threshold using amber bottles 
To confirm, the findings of our novel olfactometer developed in-hose, the odor threshold for 
hexanal was also determined using amber bottles. Ten of the previous volunteers sniffed air 
from a bottle (60 ml) containing 10 ml of diluted hexanal with the same concentrations as in 
the case of olfactometer, as confirmed by GC analysis of the three highest concentrations, 
starting with lowest concentrations. For further details please see the Method and Material 
section of Paper II. 
3.4 EXPOSURE OF MICE TO ACROLEIN (PAPER III) 
The sub-chronic pulmonary toxicity induced by acrolein in seven female inbred mice strains 
129S1/SvlmJ, A/J, BALB/cByJ, C3H/HeJ, C57BL/6J, DBA/2J and FVB/NJ mice (age: 12-
14 weeks) was examined. These mice were obtained from the Jackson Laboratory (Bar 
Harbor, ME, USA) and housed under specific pathogen-free conditions at the animal facility 
of the New York University Medical School (New York, NY, USA), with food and water 
provided ad libitum. This study was approved by the Institutional Ethical Board (reference 
no. 100684). 
3.4.1 Mice exposure 
Mice (one group 5 for each strain) were subjected to whole-body exposure to filtered air with 
and without acrolein in 1.3-m
3
 stainless steel inhalation chambers for 6 hours per day, 4 to 5 
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days per week for a total of 11 weeks.  Acrolein gas was generated by passing charcoal and 
HEPA-filtered air over acrolein in a glass flask and the chamber concentration target of 1 
ppm with a Miran 1A. The actual chamber concentration was 1.03 ± 0.03 ppm (mean ± SD). 
To obtain tissue for mRNA and protein analysis the diaphragm was punctured, the chest 
cavity opened and the lungs excised, frozen in liquid nitrogen, and stored (-80° C).     
3.4.2 Bronchoalveolar lavage  
Bronchoalveolar lavage (BAL) was performed immediately after exposure by cannulating the 
trachea and infusing the lungs two times with 1.2 ml of Dulbecco’s phosphate buffered saline 
(PBS) without calcium and magnesium. Analysis of BAL cell differentials and BAL total 
protein content was performed. A detailed description is presented in Material and Method 
section of Paper III. 
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3.4.3 Preparation of lung homogenate 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Preparation of lung homogenate for extraction of RNA 
 
3.5 RNA/CDNA SYNTHESIS  
RNA was extracted from the lysed airway mucosa model (Paper IV) and mouse lung samples 
were extracted in accordance with the manufacture’s instruction using total RNA isolation 
and reverse transcription and qRT-PCR performed by using RNeasy Mini Kit (Quiagen). The 
High Capacity RNA-to-cDNA kit (Applied Biosystems) was utilized for reverse transcription 
and the concentration of mRNA were subsequently assessed by spectrophotometrically 
(260/280 nm ratio, NanoDrop 1000, Thermo Scientific).  
Lung tissue (approximately 30 mg) 
600 ul of RLT buffer in Precelly tubes 
Cut into small pieces 
Homogenization of tissue 
Centrifuge at 2000 rpm for 2 minutes 
  Centrifuge at 6500 rpm for 3 minutes 
Transfer lysate into new RNase free tube   
Collect supernatant for RNA extraction 
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3.6 MARKERS ANALYZED WITH THE REAL-TIME POLYMERASE CHAIN 
REACTION  
The primers used for gene amplification are specified in Table 1 (Material and Method 
sections of Papers III and IV). β-Actin was used as a housekeeping gene for normalization of 
the relative levels of  mRNA. In the lungs of the inbred strains of mice the levels of mRNA 
encoding the pro-inflammatory markers Nfkb, Tnfa, Il6, Il17b, Cxcl1, Mip2 the markers of  
oxidative stress Gp1, Gpx3, Sod3, Ho1 and markers of tissue injury/repair Mmp9/Timp1 were 
analyzed. 
In addition, levels of mRNA encoding the pro-inflammatory markers IL8, MMP9, NFKB, 
TNFA, IL6 and the markers of oxidative stress HMOX1 were determined in the  PBEC-ALI 
and PBEC-Submerged.  
3.7 EXPOSURE OF THE AIRWAY MUCOSA MODEL (PAPER IV) 
3.7.1 Primary bronchial epithelial cells  
PBEC, obtained from Karolinska Hospital in connection with lobectomy, were isolated and 
cultured according to Strandberg and colleagues (2007) with certain modifications [87]. This 
study received ethical approval from  Karolinska Hospital (KI forskningsetikkommitte Nord, 
Dnr.99-357).  
3.7.2 Culturing human lung fibroblasts  
Medical Research Council cell strain-5 (MRC-5, lung fibroblasts) cells, originally derived 
from a 14-week male fetus, were obtained from American Type Cell Culture (passage 27 was 
used), cultured submerged in a Petri dish and placed upside down on inserts to construct the 
mucosa model (Figure 10 B).  
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A. Timeline
 
B. Procedure 
 
C. Exposure system, adapted from Paper IV with permission from publisher. 
 
Figure 10: The airway mucosa model and exposure system  
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3.7.3 The chamber for exposure of cells 
The mucosa models were exposed to aldehyde vapors (generated in a 10-liter Tedlar bag) in a 
small exposure chamber of glass (Figure 10 C). The bag was attached to the exposure 
chamber and the aldehyde vapor was pumped through at a flow rate of 0.4 liter/minute. To 
ensure even distribution, a magnetic stirrer was placed at the bottom of the chamber. A sterile 
filter was attached to the inlet tube. The humidity in the exposure chamber was maintained at 
45-50% by a humidifier connected to the inlet air.  
The mucosa models were introduced into this chamber immediately prior to exposure. The 
outlet of the chamber was connected to a gas chromatograph for analysis of the actual 
concentration in the chamber air (Figure 10) five times during the 30-minutes exposure. For 
further details please refer to Paper IV.  
3.7.4 Exposure at air-liquid interface  
PBECs from three donors were exposed in triplicate to aldehyde vapors for 30-minutes, 
followed by incubation in the absence of aldehyde up to 24 hours. Control exposure to clean 
air without aldehyde  was carried out (in an identical manner). Both the basal medium (BM) 
and apical medium (AM) were collected 8 and 24 hours post-exposure for analysis of IL-8 
and MMP-9 levels by enzyme-linked immunosorbent assay (ELISA). On the basis of these 
findings gene expression was performed at 6 hours post exposure with the real time 
polymerase chain reaction (qRT-PCR). For a full description, please see Paper IV. 
3.7.5 Submerged exposure 
PBEC were grown on 24 well plates in keratinocytes serum free medium (KSFM) and at sub-
confluence, exposed to acrolein, crotonaldehyde and hexanal for 30 minutes. Subsequently, 
the culture medium was replaced with new medium incubation continued up to 24 hours and 
gene expressions, IL-8 and MMP-9 release were determined with the qRT-PCR and ELISA, 
respectively.  
3.7.6 Cell viability 
The viability of the PBECs was tested at 8 and 24 hours after exposure by staining with 
Trypan blue 200 µl of 0.4% in PBS for 1 minute, follwed by washing with PBS, and 
evaluating of dye exclusion under a bright-field microscopy. 
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3.7.7 Enzyme-linked immunosorbent assay  
IL-8 and MMP-9 were assayed with the Human CXCL/IL-8 duo set and Human MMP-9 duo 
Set (R&D Systems, Minneapolis, MN), respectively, in accordance with the manufacture’s  
protocol. The limits of detections (LOD) were 31.2 and 15.6 pg/ml for IL-8 and MMP-9, 
respectively. 
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4 RESULTS AND DISCUSSIONS 
In the following section, the results and discussions from the studies carried out in this thesis 
are presented. 
4.1 EXPOSURE OF HUMANS VIA INHALATION 
As a first step, a pilot study was performed to identify appropriate exposure levels for the 
main study. 
4.1.1 The pilot study  
The rating of smell increased immediately when the volunteers entered in the exposure 
chamber, even at a level of 0.02 ppm (median rating of 13 mm, Figure 11), a concentration 
lower than the 0.03 ppm reported previously (Sinkuvene 1970, cited in [88]) and higher than 
the 0.0036 ppm employed by Nagata (2003) [89]. Nagata’s subjects were trained, which 
might explain their ten-fold greater smell sensitivity compared to naïve volunteers [89].   
Since it was possible that, our volunteers detected odor while entering the chamber, simply 
because they were expected to smell acrolein, we compared the ratings of smell in the pilot 
and for the clean air the main study (3 minutes) and found that the median rating of odor in 
the pilot study was twice as high as compare to main study. Thus, we concluded that 
volunteers actually did perceive the odor of acrolein at 0.02 ppm. Increasing this level had no 
effect on their smell ratings, since humans adapt quickly to smell.  
With respect to that the dose-effect relationship of irritation, i.e. a significant increase in 
throat irritation (p= 0.006) for the 50
th
 percentile (median) and a tendency towards enhanced 
eye irritation (p= 0.066) for the 75
th
 percentile (Figure 1 B and C; Paper I) were revealed by 
logistic quantile regression. This analysis also indicated a dose-effect relationship up to 0.3 
ppm in the pilot study, in agreement with Weber-Tschopp and coworkers (1977) [17], who 
also observed throat irritation at 0.3 ppm. No other clear effects could be detected on other 
ratings. 
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Figure 11: The relationship between rating of smell and the level of exposure. The curves 
represent the 25
th
, 50
th
 (median), and 75
th
 percentile and each dots represent individual 
ratings. Adapted from Paper I, with permission from publisher. 
4.1.2 The main study 
4.1.2.1 Ratings of symptoms  
The rating of eye irritation increased slightly, but significantly during exposure to acrolein in 
a dose-dependent manner (p <0.001, Friedman test), with a median value of 8 mm (slightly 
more than ‘‘hardly at all’’) after 118 minutes at 0.01 ppm, with no influence of EA. This 
finding of eye irritation as a critical effect of acrolein exposure is in line with the observations 
of Weber- Tschopp and colleagues (1977), in connection with three scenarios for exposure to 
acrolein in which irritation was rated on the basis of questionnaire, frequency of blinking and 
respiration rate [17]. Three other studies that also document eye irritations following 
exposure to acrolein are limited by their use of much higher concentrations for shorter 
periods [90-92].  
Development of sensory irritation is a complicated process with time that depends on the 
nature of test compound and such irritation may disappear with time or even re-appear after a 
short period. However, within a given time frame (several minutes and longer) sensory 
irritation is more heavily dependent on the concentration than the duration of exposure [93]. 
Although our experiment which suggests that the rating of eye irritation after 3 minutes was 
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only marginally higher than pre-exposure ratings, these ratings continued to rise with the 
time, especially during the first hour of exposure to acrolein. Accordingly, Weber-Tschopp 
and colleagues (1977) reported an elevation in eye irritation during the first 20–30 minutes of 
exposure to 0.3 ppm acrolein, after which a plateau was reached [17].  
Rating of nasal irritation were low and statistically insignificant under all conditions of 
exposure except for 0.1 ppm acrolein in combination with EA. Nasal irritation has been 
reported by previously only at very high concentrations [17]. 
Ratings of smell increased immediately after the volunteers entered the chamber and more so 
upon exposure to EA than acrolein exposure, as expected, Lang and coworkers (2008) have 
proposed that the profound odor of EA influences rating of irritation, since, no significant 
effects were found upon co-exposure to 15 ppm EA [94]. Thus, sensory perception of 
irritation may be hindered by strong odor [95]. 
In our investigations, ratings of throat irritation, fatigue and other CNS symptoms were 
unaffected by exposure to acrolein and/or EA. The only gender differences observed were 
that women gave higher ratings after 60 minutes of exposure to 0.05 ppm acrolein, as well as 
the day after exposure to 0.1 ppm acrolein in combination with EA. 
 
Figure 12: The relationship between rating of eye irritation and the serum amyloid A (SAA) 
ratio (after/before exposure). The dots represent individual ratings. The curves represent the 
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25
th
, 50
th
 (median), and 75
th
 percentile. Adapted from Paper I, with permission of the 
publisher. 
The only significant correlation between any of the ratings and the levels of inflammatory 
markers in blood involved ratings of eye irritation and the SAA ratio (Figure 12). Analysis by 
logistic quantile regression revealed that the most sensitive subjects (i.e., those who rated 
highest) exhibited a significant association (75
th
 percentile, p =0.026) with a higher ratio of 
SAA following exposure to acrolein (Figure 12), perhaps due to up-regulation. Conklin and 
coworkers (2011) have also shown that acrolein up-regulates SAA in mice [96], which is a 
consequence of TRPA1 mediated inflammatory responses to environmental irritants such as 
acrolein and mustard gas [72]. The different subtypes of TRPA1 (3–4 haplotypes) [97] might 
thus help explain the variation in the ratings by our volunteers.  
4.1.2.2 Effects on the eyes, airways, and nose 
The frequency of blinking, as which was recorded by electromyography, was slightly higher 
during the final 20 minutes of exposure to 0.1 ppm acrolein compare than during to the first 
20 minutes of exposure (p = 0.049, ANOVA), an effect not observed with any of the other 
conditions of exposure  (Table 2, Paper 1). A significantly elevated blinking frequency during 
exposure to acrolein has also been reported by Weber-Tschopp and co-workers (1977), albeit 
at a higher level (0.26 ppm) [17]. Our volunteers were about 24 years old and young people 
are less sensitive to irritants than the elderly because of their more robust formation of a film 
tears. There were no exposure-related effects on the breathing frequency, pulmonary function 
and nasal parameters and no gender differences with the exception of higher FEV1/VC and 
FEV1/FVC ratios for women, irrespective of exposure, and higher VOL1 and MCA1 values 
for the men.  
4.1.2.3 Markers of inflammation and coagulation in the blood and sputum 
The levels of markers of inflammation and coagulation in the blood (IL-6, CRP, SAA, 
fibrinogen, factor VIII, vWF and CC-16) were not influenced by exposure to acrolein (IL-6 
was tested only at 0 and 0.1 ppm) nor were the cell count, differential cell count, levels of IL-
6 and IL-8 in the induced sputum (Supplement material to Paper I, Table 6). There were no 
gender differences with respect to any of the markers measured.  
Previously the sputum of smokers has been shown to contain elevated number of 
inflammatory cells. Moreover, the level of IL-8, a chemoattractant for neutrophils, is 
increased in both the upper and lower airways of smokers [98]. The level of IL-6, a pro-
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inflammatory cytokine is also enhanced in the airways in response to an inflammatory 
stimulus. Since acrolein is highly water soluble we could have chosen to measure these 
biomarkers in nasal lavage fluid or exhaled breath air condensate (EBC) instead.   
In conclusion, this investigation demonstrated minor subjective eye irritation at short-term 
exposure to 0.1 ppm acrolein. These findings are inconsistent with those of Weber-Tschopp 
and colleagues (1977), who observed a significant increase in eye irritation at a level of 0.09 
ppm [17].  
4.2 THRESHOLDS FOR ODOR AND LATERALIZATION  
There is considerable discrepancy concerning how to present odor and, consequently, a wide 
range of detection thresholds for odor and lateralization have been reported. Odors are either 
presented to subjects in amber bottles or employing expensive and technically challenging 
olfactometers. 
4.2.1 Validation of our olfactometer 
To deliver an accurate vapor concentration we developed a novel, yet simple olfactometer 
that responds rapidly and reliably to a shift in valve position (Figure 8).  The findings upon 
exposure to vapors of acrolein, crotonaldehyde and hexanal confirmed that this olfactometer 
provides reliable values for thresholds for odor and lateralization. The air at the tip of the 
nose, 90% of the target concentration was attained within 15 seconds (Figure 8). The 
presentation timing which is dependent on the rate of air flow is less than 1 minute. This time 
can be shortened even more by accelerating the air flow, but this might drying out the 
respiratory lining, thereby triggering pain sensation and preventing precise measurements 
[99, 100]. 
Kobal and colleagues (1991) have also proposed that for odorous irritants, like aldehydes the 
interval between stimuli should be longer. The results of the amber bottle test here validate 
that our presentation method was reliable, i.e., the order of odor thresholds for all ten 
volunteers were the same order as with both procedures.[101]. 
4.2.2 Odor thresholds 
The OT data for each volunteer are presented in Figure 13. The median OT for acrolein was 
17 ppb, with range of 2.7–88.5 ppb (Figure 13).This median value is higher than the 3 ppb by 
Nagata (2003) [89] but lower than the 160 ppb found by Amoore and Haluta (1983) [101]. 
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Unfortunately, only two of our 18 volunteers could smell acrolein even at the highest 
concentrations tested. 
Eleven of 20 volunteers detected the odor of crotonaldehyde at the lowest concentration 
tested (i.e., 0.8 ppb) (Figure 13), whereas, two volunteers did not detect any odor even at the 
highest concentration (92.5 ppb). Thus our OT value for crotonaldehyde (0.8 ppb) was lower 
than the previously described values of 120 ppb by Amoore and Haluta (1983) [101] and 23 
ppb by Nagata (2003) [89]. 
The median OT for hexanal was 97 ppb (11.7–3911 ppb) (Figure 13), which is higher than 
the previously published values of 25 ppb [73], and 11 ppb [102]. Again, two subjects could 
not detect any odor even at the highest concentration of hexanal tested. Nagata (2003) used 
trained subjects, whereas ours were naïve volunteers and we found considerable intra-
individual variability in the ability to perceive odors [89].  
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Figure 13: The odor thresholds for three aldehydes. Each dot represents the threshold in one 
individual. The horizontal lines represent medians. Adapted from Paper II, with permission 
from publisher. 
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4.2.3 Lateralization thresholds 
The individual findings on LT are presented in Figure 14. Although we tested higher 
concentrations as high as 2940 ppb, LT for acrolein could be established only for one of the 
20 volunteers, who had a value of 10.7 ppb. Published data regarding the irritation threshold 
for acrolein are scare. In the previous described pilot study where 8 healthy volunteers were 
subjected to whole-body exposure to seven levels acrolein for 10 minutes up to 300 ppb, one 
subject rated marked nasal irritation at 40 ppb, while the other seven experienced little or no 
irritation at any level. Moreover, no nasal irritation was obtained in the main study with 
exposure at 0, 50 and 100 ppb for 2 hours. At the same time, there was large inter-individual 
variability in sensitivity to acrolein. 
Several reports indicate irritation by acrolein is mediated by the TRPA1. For instance, 
TRPA1-deficient mice are insensitive to sensory irritation caused by acrolein and other 
electrophilic substances [77]. The underlying mechanism is presently being elucidated. Some 
scientists propose that acrolein covalently modifies the TRPA1 protein in a manner that opens 
the cation channel, thereby initiating neuronal depolarization and calcium ion influx into 
sensory nerve endings [103]. In our study, the combination of short exposure time with low 
concentrations of acrolein may explain why a LT was obtained for only one volunteer.  
 
 
Figure 14: Lateralization threshold for three aldehydes. Each dot represents the threshold in 
one individual. The horizontal lines represent median. Adapted from Paper II, with 
permission. 
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The median LT for crotonaldehyde, observed in 8 volunteers was 3 ppb, a value much lower 
than the 170 ppb threshold for mucous membrane irritation of 170 ppb reported by Trofimov 
(1962) [104].  
Hexanal LTs were reported by 6 of our 20 volunteers, with a median value of 390 ppb, which 
corresponds well with the LT of 281 ppb for sensory irritation (also based on ratings) 
reported by Li Zheng (2010) [73]. With our previous whole-body inhalation exposures to 
hexanal (0, 2000 and 10000 ppb for 2 hours), ratings of nasal irritation increased at 2000 ppb, 
starting at 60 minutes. Taking into consideration the differences in route of exposure (nose 
only versus whole body), exposure duration (5 seconds versus 2 hours) and endpoint 
measurement (categorical versus magnitude) between these two studies, the findings agree 
reasonably well. Therefore, we propose individual variation in trigeminal intranasal 
sensitivity is more pronounced for aldehydes than for other irritants.  
4.3 EXPOSURE OF MICE TO ACROLEIN  
Variation in individual susceptibility to acute lung injury induced by acrolein particularly at 
high levels is well known. The survival time of 40 inbred strains of mice differed more than 
two-folds after exposure to 10 ppm acrolein, BALB/cByJ mice (17 h) and 129X1/SvJ mice 
(>40h), strongly indicating a genetic predisposition [105]. In that investigation the inbred 
strains of mice selected for our study of response to sub-chronic exposure to acrolein (1 ppm) 
exhibited the following survival times: BALB/cByJ (17h); C57BL/6J (22h); 129S1/SvlmJ 
(25h), DBA/2J (27h), C3H/HeJ (29h), A/J (30h), and FVB/NJ (33h).  
4.3.1 Branchoalveolar lavage  
Total numbers of cells in BAL and protein content were not altered in any of the strains after 
exposure. These finding justify our use of low dose and sub-chronic exposure. Kashara and 
coworkers (2008), made similar observations, with no recruitment of inflammatory cells 
following exposure of C57BL/6J mice to sub-toxic concentrations of acrolein (5 ppm, 6 
hours/day for up to 3 days), which were considered to be representative of indoor exposures 
[106]. 
4.3.2 Markers of inflammatory and oxidative stress markers 
Several mediators play crucial roles in chronic inflammatory processes and apparently 
determining the nature of the response by the selectively recruiting and activating 
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inflammatory cells and regulating how long these cells remain within the lungs. Increased 
(2.5-3.5 fold) pulmonary levels of Il17b mRNA in the exposed BALB/cByJ, C57BL/6J and 
129S1/Svm mice was detected in our study (Figure 15). These three strains employed the 
most sensitive to acute lung injury induced by acrolein by Leikauf and colleagues, 2011 
[105]. IL-17b has been associated with enhanced recruitment of neutrophils in mice models 
of asthma [107]. Although, we could not detect any change in total cell number in BAL fluid, 
the elevated levels of Il17b mRNA may be associated with susceptibility to lung damage by 
acrolein.  
Oxidative stress, including exposure to products of lipid peroxidation and/or depletion of 
reduced glutathione, causes rapid ubiquitination and phosphorylation with subsequent 
degradation of the IκB complex, a critical step of Nfkb1 activation. Brenan and colleagues 
(1995) found that oxidative stress promotes the activation and translocation of Nfkb1 to the 
nucleus, although, activation of Nfkb1 in association with oxidative stress is highly cell 
specific [108]. The elevation in pulmonary levels of mRNA encoding Nfkb1, as well as Sod3, 
Gpx1 and 3 in the mice to exposed acrolein strongly supports the presence of oxidative stress. 
Several investigations both in vivo and in vitro have also demonstrated that both reactive 
oxygen species and Tnfα promote activation of Nfkb1 as well as of Il6 and Cxcl2/Mip2 [109-
111]. 
The elevated pulmonary levels of Nfkb1 lung transcripts in BALB/cByJ, C57BL/6J and 
129S1/SvlmJ mice exposed to acrolein may result in a substantial pro-inflammatory reaction. 
Nfkb1 signaling is a key determinant of airway hyper-responsiveness to inhaled agents [112]. 
Indeed, activation of the Nfkb1 pathway is sufficient to induce acute lung injury and also 
exerts considerable impact on other central biological processes, including host defenses 
[113].   
Of the numerous reports on the regulation of inflammatory responses to environmental stress 
via the Nfkb1 pathway, several have focused on immune cells. However, Cheng and co-
workers (2007) demonstrated that Nfkb1 signaling in non-immune cells is also a critical 
determinant of pulmonary responses to harmful stimuli. Human studies also support the role 
of Nfkb1 dependent mediators in inducing lung injury, although the cell that generate these 
mediators are not yet well defined.  Many researchers [112, 113], have reported that 
activation of Nfkb1 in airway epithelial cells of mice enhances expression of several 
cytokines and chemokines including IL6, granulocyte colony stimulating factor (G-csf), 
granulocyte macrophage colony stimulating factor (Gm-csf), Cxcl2/Mip-2, Cxcl1(aka 
keratinocyte-derived chemokine/Kc), Il17 etc.  
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The findings described above are comparable with our present observation that sub-chronic 
exposure to acrolein results in induction of Nfkb1 as well as Nfkb dependent mediators (Il6, 
Cxcl1) that may be involved in causing lung injury in susceptible mice strains over time 
(Figure 15).  
4.3.3 Markers of tissue injury/repair  
Activation of Mmp9, the predominant matrix metalloproteinase of the airway epithelium, can 
be promoted by acrolein, at concentration similar to those present in the sputum of patients 
with chronic bronchitis patients [114]. An imbalance of anti-proteinases and proteinases, in 
particular Mmps and Timps, is an important aspect of the pathogenesis of chronic lung 
diseases [114, 115]. Expression of Mmp9 is also regulated by numerous stimulatory factors, 
including several pro-inflammatory cytokines and endogenous inhibitors, such as 
Timps [116-118]. Unaltered Timp1 and 2 appear to be involved in the activation of Mmp9 
mediated overproduction of mucus [114]. Therefore, our current finding that acrolein elevates 
the level of Mmp9 and unaltered Timp1 transcript expression in mice is indicative of 
susceptibility. On the basis of the scoring matrix discussed above, involving oxidative stress, 
along with markers of inflammation and tissue injury, we propose that the susceptibility of 
the mice strains tested (in descending order) to pulmonary toxicity as a consequence of sub-
chronic exposure to acrolein is as follows: C57BL/6J, 129S1/SvlmJ, BALB/cByJ, C3H/HeJ, 
A/J, DBA/2J and FVB/NJ. 
 
In conclusion, in seven inbred strains of mice commonly used in respiratory research sub-
chronic exposure to a low dose (1 ppm) of acrolein does not lead to acute lung injury. 
Nevertheless, several significant and selective changes in the levels of markers of oxidative 
stress, pro-inflammation and tissue injury can apparently discriminate between sensitive and 
resistant strains. This finding provide further evidence that acrolein is involved in the 
impairment of innate immune responses that may predispose to chronic lung diseases. 
Clearly, chronic exposure studies with these mice strains might help to unravel the 
mechanisms underlying acrolein-mediated lung toxicity. 
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Figure 15: Lung transcript analysis of pro-inflammatory markers in seven mouse strains exposed 
to filter air or acrolein (1 ppm, 6 hours/day and 4-5 days/week for 11 weeks) 
 
Filter air (Control) 
1 ppm acrolein  
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4.4 EXPOSURE OF THE AIRWAY MUCOSA MODEL 
Here, we examined the inflammatory responses and cytotoxicity of aldehydes employing the 
airway mucosa model and under submerged conditions. In addition, we established that 
exposure to α, β-unsaturated aldehydes enhance oxidative stress and inflammation as 
indicated by changes at both protein and mRNA levels in PBEC-ALI. In contrast, submerged 
exposures to acrolein and crotonaldehyde significantly reduce the IL-8 secretion along with 
the expression of IL8 and NFKB. The effects of hexanal were less pronounced effects but 
there was still elevated secretion of IL-8 upon exposure at ALI and increased expression of 
TNFA under submerged conditions. 
4.4.1 Cell viability 
Cell viability (as assessed by exclusion of trypan blue) was reduced only at the two highest 
concentrations of acrolein and crotonaldehyde tested. These α, β- unsaturated aldehydes bind 
to glutathione, cause oxidative stress and may lead to cell death via either apoptosis or 
necrosis. Others have also reported that at high doses both acrolein and crotonaldehyde 
decrease the viability of primary cells or cell lines [119, 120]. No change in viability was 
observed at any concentration of hexanal, which is known to be less potent than these two 
other aldehydes. 
4.4.2 Changes in the levels of IL-8 and MMP-9  
4.4.2.1 PBEC-ALI model 
With this model release of IL-8 in the basal medium was unaltered  following 8 or 24 hours 
after exposure to acrolein, with crotonaldehyde the dose-effect relationship was inverted  U-
shaped with highest levels of IL-8 in the basal medium after exposure to the two intermediate 
concentrations, both at 8 (1 and 2 ppm) and 24 hours (1 and 2 ppm). In comparison to clean 
air exposure, the level of this cytokine was significantly elevated following 8 hours of 
exposure to hexanal at all concentrations tested. In the apical medium release of IL-8 was 
attenuated after exposure to 0.2 ppm acrolein at 24 hours and 1 ppm crotonaldehyde at 8 
hours.  
It is well established that aldehydes cause inflammation and promote the generation of 
reactive oxygen species both in vivo and in vitro [20, 121-124] including on higher doses, 
under submerged conditions and in cell lines [124-127]. However, little quantitative 
information concerning gaseous exposure at an ALI is presently available. The basal/apical 
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release of IL-8 by the PBEC-ALI model observed here was in agreement with the findings by 
Mio and colleagues (1997), who found that acrolein elevates IL-8 release in human bronchial 
epithelial cells in a concentration-dependent manner, with a peak response at 10 μM (0.56 
mg/L) acrolein in the medium [126]. 
Here, exposure of PBEC-submerged to 0.1 and 0.2 mg/L acrolein significantly attenuated 
secretion of IL-8 and MMP-9 at both concentrations and time points (6 and 24 hours), while 
crotonaldehyde reduced the level of IL-8 following  6 (1 mg/L) and at 24 hours (2 mg/L) of 
exposure, as compared to sham. The level of MMP-9 was not affected by crotonaldehyde or 
hexanal under the submerged conditions. The present findings are consistent with previous 
indications that acrolein and crotonaldehyde can act either in an immunosuppressive [124, 
125] or pro-inflammatory manner depending on the cell type and concentrations [27, 122, 
123, 128]. We found lowered levels of both IL-8/IL8 mRNA and protein after submerged 
exposure to acrolein. The inflammatory response is characterized by coordinate activation of 
various signaling pathways that regulates expression of both pro- and anti-inflammatory 
mediators.  
The level of MMP-9 in apical medium was significantly increased after 8 and 24 hours to 
exposure to 2 and 5 ppm of crotonaldehyde, 20 and 50 ppm hexanal, respectively. 
Furthermore, this level was higher in the apical than the basal medium following 8 and 24 
hours of exposure to all concentrations of acrolein, hexanal and crotonaldehyde tested (with 
the exception of  5 ppm crotonaldehyde), despite the difference in collection time (15 minutes 
apical medium vs 8 hours/24 hours basal medium).  
MMP-9 is a type IV collagenase involved in remodeling and aldehydes may promote its 
epithelial secretion by causing damage that requires remodeling of extracellular matrix 
(ECM), probably to achieve rapid re-epithelialization [116]. Atkinson and colleagues (2003) 
also attributed a substantial modulating effect on other enzymes and cytokines to MMP-9. 
Therefore, the significant rise in apical levels of MMP-9 in our ALI models could reflect a 
first line of defense that triggers and potentiates subsequent cascades, including recruitment 
and stimulation of the innate immune system [116]. In this context, MMP-9 is known to 
evoke a ten-fold increase in the IL-8 induced chemotaxis of neutrophils [129].  
4.4.3 Changes in m-RNA levels 
The levels of mRNA encoding HMOX1, a marker of oxidative stress and TNFA, an 
inflammatory marker were significantly upregulated after 6 hours exposure to 0.1 and 0.2 
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ppm acrolein. Exposure to 2 ppm crotonaldehyde elevated the levels of HMOX1, TNFA and 
NFKB mRNA, while the levels of MMP9 mRNA were significantly increased by exposure to 
1 ppm crotonaldehyde after 6 hours.  
Human bronchial epithelial cells was exposed to 5–20 μM (0.3–1.1 mg/L) acrolein for 12 
hours under submerged conditions have been reported to have significantly elevated levels of  
HMOX1 mRNA [130]. In contrast, to our exposure of submerged PBECs to 0.1 mg/L 
acrolein resulted in significant down-regulation of HMOX1. Previously, exposure of 
submerged human adenocarcinoma lung cells (A549) to 100 μM acrolein (5.6 mg/L) for 1 
hour was found to down-regulate 478 genes and up-regulate of 139 others, including HMOX1 
[131]. These discrepancies in the HMOX1 response may reflect the use of different dose (50 
fold higher concentration), cell types (primary cells versus cell lines), and duration of 
exposure, as well as post exposure incubation. Moghe and co-workers have also proposed 
that the levels of exposure (acrolein) can explain much of such discrepancies between 
different studies [27]. 
We observed significant down-regulation of NFKB along with an elevated of HMOX1 
mRNA following submerged exposure to 1 mg/L crotonaldehyde, which agrees with findings  
by Liu and colleagues (2010) at higher levels exposure (40 μM, (2.8 mg/L)) [51]. Moreover, 
Liu and colleagues, 2010 [50] also observed up-regulation of HMOX1. As confirmed by 
sequencing of the human HMOX1 promoter, HMOX1 induction involves of multiple 
signaling cascades regulated by oxidants and electrophiles (such as acrolein and 
crotonaldehyde), which supports our findings of up-regulation of HMOX1 after exposure at 
ALI. 
However, we found that 20 mg/L hexanal significantly up-regulated TNFA, a key mediator of 
inflammatory responses under submerged conditions. TNF-A is a key molecule which is 
responsible for of the inflammatory change. Although, not well studied as an aldehyde 
hexanal may cause oxidative stress and affect a variety of biological processes. In support of 
this suggestion, transcriptome analysis of human alveolar cells (A549) exposed to hexanal 
revealed changes in gene expression associated specifically with pulmonary effects [66, 132]. 
To summarize, the responses of the airway mucosa model to aldehydes are similar to in vivo 
responses, whereas, responses under submerged conditions are not. Thus our novel PBEC-
ALI system with exposure via air provides a useful model for studying the inflammatory and 
other adverse effects of inhaled agents. 
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5 CONCLUDING REMARKS 
We have performed exposure studies with different experimental models which ranges from 
human subjects to animal models and to advanced cell models based on primary human cells. 
The aim of this thesis was to characterize irritation and inflammation caused by exposure to 
aldehydes, with the main focus on acrolein. Our human exposure study showed, that the most 
prominent effect was eye irritation, but there was tendency towards throat irritation and as 
well as a positive association between ratings of eye irritations and the level of SAA in blood 
suggesting up-regulation of this marker in the most sensitive subjects only. The threshold of 
irritation by the aldehydes tested was low. In mice exposure to acrolein exert the most 
pronounced impact on the most sensitive strains, up-regulating the markers of pro-
inflammation and oxidative stress in the three most sensitive strains. Furthermore, exposure 
of the airway mucosa model to acrolein and crotonaldehyde vapors cultured at an air-liquid 
interface resulted in up-regulation of inflammatory markers, in line with in vivo findings. 
These effects were limited, probably because the exposure levels were low and comparable to 
realistic exposure in the indoor and outdoor environments. Altogether, our findings indicate 
that low levels of vapors of aldehydes may cause irritation and inflammation, at least in the 
more susceptible individuals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
50 
 
6 FUTURE PERSPECTIVES 
Acrolein may exert toxic effects on the entire respiratory tract, from the nasal epithelium to 
the alveolar spaces. Development of an airway mucosa model including nasal epithelium and 
alveolar sacs by further refinement of our model would be of considerable value. This 
research strategy might involve developing a lung-on-a-chip or whole body-on-a-chip with 
tools that could be coupled to realistic delivery of puffs of cigarette smoke. 
Although acrolein has been thoroughly studied, individual differences in susceptibility to its 
acute pulmonary toxicity still need to be explored. Crotonaldehyde has effects similar to 
those of acrolein, but is less well studied and investigation on primary cells could provide 
deeper insight into its toxic effects. Hexanal is the least well-characterized of the three tested 
aldehydes and requires more focus. 
Increasing incidences of chronic lung diseases such as asthma and COPD have been closely 
linked to rising air pollution in cities worldwide. As ubiquitous presence of aldehyde 
pollutants and potent airway irritants (acrolein, crotonaldehyde and hexanal) are all of interest 
and may indeed have synergistic interactions that could be looked with our airway mucosa 
model. Since these aldehydes may have synergies, their combinatory toxicity might be higher 
than the one observed individually. 
Our novel olfactometer allows better control of timing of presentation and vapor 
concentration and there was a tendency towards lower OT and LT values. However, we could 
not determine any irritation threshold for acrolein. Additional evaluation of the reliability and 
validity of this olfactometer is required.  
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